Want to grow your portfolio? Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
Organogenesis Holdings Inc trades on the NASDAQ. ORGO's market cap is 2.7 Billion.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.